Active Ingredient History
Selenium sulfide, an anti-infective agent, relieves itching and flaking of the scalp and removes the dry, scaly particles that are commonly referred to as dandruff or seborrhea. It is also used to treat tinea versicolor, a fungal infection of the skin. Topical selenium sulfide can be added to the therapeutic armamentarium for congenital or acquired hyperkeratosis. NCATS
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Dermatitis, Seborrheic (approved 1951)
Abdomen, Acute (Phase 4)
Acute Kidney Injury (Phase 2)
Alzheimer Disease (Phase 3)
Antioxidants (Phase 4)
Arsenic (Phase 3)
Arsenic Poisoning (Phase 3)
Asthma (Phase 2)
Brain Death (Phase 3)
Breast Neoplasms (Phase 2)
Burns (Phase 4)
Cardiomyopathies (Phase 4)
Cardiovascular Diseases (Phase 4)
Cataract (Phase 3)
Central Serous Chorioretinopathy (Phase 2)
Chagas Disease (Phase 3)
Colorectal Neoplasms (Phase 3)
Critical Illness (Phase 4)
Deficiency Diseases (Phase 4)
Depression (Phase 3)
Endometriosis (Phase 2)
Graves Ophthalmopathy (Phase 2/Phase 3)
Hashimoto Disease (Phase 4)
Heart Arrest (Phase 2)
Heart Diseases (Phase 3)
Heart Failure (Phase 3)
Hematopoietic Stem Cell Transplantation (Phase 3)
Infant, Premature, Diseases (Phase 2)
Infertility (Phase 4)
Infertility, Male (Phase 4)
Inflammation (Phase 3)
Ischemia (Early Phase 1)
Ischemic Stroke (Early Phase 1)
Keratosis (Phase 3)
Kidney Calculi (Phase 4)
Kidney Failure, Chronic (Phase 3)
Liver Diseases (Phase 4)
Lung Neoplasms (Phase 3)
Lymphatic Diseases (Phase 1)
Lymphedema (Phase 2)
Macular Degeneration (Phase 3)
Malaria (Phase 3)
Malnutrition (Phase 3)
Mucositis (Phase 1/Phase 2)
Multiple Myeloma (Phase 1)
Multiple Sclerosis (Phase 1/Phase 2)
Mycobacterium tuberculosis (Phase 3)
Neoplasms (Phase 3)
Oral Submucous Fibrosis (Phase 3)
Osteoporosis (Phase 3)
Oxidative Stress (Phase 3)
Pancreatitis (Phase 2/Phase 3)
Plasmacytoma (Phase 1)
Postoperative Complications (Phase 2/Phase 3)
Precancerous Conditions (Phase 3)
Pregnancy (Phase 4)
Prostatic Neoplasms (Phase 3)
Pulmonary Disease, Chronic Obstructive (Phase 4)
Purpura, Thrombocytopenic, Idiopathic (Phase 2/Phase 3)
Selenium (Phase 4)
Semen Analysis (Phase 4)
Sepsis (Phase 4)
Shock, Septic (Phase 3)
Stomatitis (Phase 3)
Subarachnoid Hemorrhage (Phase 3)
Thoracic Surgery (Phase 3)
Thyroiditis, Autoimmune (Phase 2)
Tinea Versicolor (Phase 4)
Urinary Bladder Neoplasms (Phase 3)
Ventricular Dysfunction, Left (Phase 3)
Wounds and Injuries (Phase 3)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
